IL1RL1 and myocarditis: Moreover, soluble ST2 (sST2) has emerged as a novel clinically cardiac biomarker with elevated levels associated with worse outcomes in heart failure and myocardial infarction (45), a similar underscored pattern in the context of ICI therapy-associated myocarditis (46, 47).